Employer profile
Olema Pharmaceuticals INC
22 open roles indexed with location, benefit, and apply-link signals where available.
Open roles
Showing the most recent indexed roles for this employer.
-
Senior Director, Global Regulatory Strategy
Boston, Massachusetts
onsite $270K-$290KSenior Director, Global Regulatory Strategy Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Senior Manager, Legal Operations & Contracts
San Francisco, California
onsite $150K-$170KSenior Manager, Legal Operations & Contracts San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete
-
Vice President Quality Assurance
Boston, Massachusetts
onsite $315K-$340KVice President Quality Assurance Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist
-
Synthetic Medicinal Chemistry Intern
San Francisco, California
onsite Salary not disclosedSynthetic Medicinal Chemistry Intern San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Senior Manager, Quality Document Control and Compliance
San Francisco, California
onsite $150K-$160KSenior Manager, Quality Document Control and Compliance San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a
-
Associate Director, Analytical Development
Boston, Massachusetts
onsite $190K-$205KAssociate Director, Analytical Development Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist
-
Senior Manager, Clinical Compliance & Inspection Readiness
San Francisco, California
onsite $150K-$170KSenior Manager, Clinical Compliance & Inspection Readiness San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a
-
Lead Senior Medical Writer
Boston, Massachusetts
onsite $160K-$175KLead Senior Medical Writer Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist
-
Senior Clinical Trial Associate
San Francisco, California
onsite $110K-$120KSenior Clinical Trial Associate San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Senior Director, Marketing
San Francisco, California
onsite $250K-$285KSenior Director, Marketing San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist
-
Vice President, Market Access
San Francisco, California
onsite $300K-$350KVice President, Market Access San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Senior Director, Commercial Manufacturing & Operations
Boston, Massachusetts
onsite $225K-$250KSenior Director, Commercial Manufacturing & Operations Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen
-
Director, CMC Drug Substance Manufacturing
Dublin, Ireland
onsite Salary not disclosedDirector, CMC Drug Substance Manufacturing Dublin, Ireland Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Associate Director, GMP Quality Assurance - Qualified Person
Dublin, Ireland
onsite Salary not disclosedAssociate Director, GMP Quality Assurance - Qualified Person Dublin, Ireland Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a
-
Senior Scientist, Medicinal Chemistry
San Francisco, California
onsite $160K-$170KSenior Scientist, Medicinal Chemistry San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Associate Director, CMC Drug Product Manufacturing
Dublin, Ireland
onsite Salary not disclosedAssociate Director, CMC Drug Product Manufacturing Dublin, Ireland Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen
-
Associate Director, GCP Quality Assurance
Boston, Massachusetts
onsite $190K-$205KAssociate Director, GCP Quality Assurance Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Program Manager, CMC
San Francisco, California
onsite $150K-$150KProgram Manager, CMC San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist
-
Associate Director, Clinical Supply Chain
Boston, Massachusetts
onsite $185K-$200KAssociate Director, Clinical Supply Chain Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor
-
Associate Director, Regulatory Affairs CMC
Boston, Massachusetts
onsite $190K-$200KAssociate Director, Regulatory Affairs CMC Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor